Research programme: VAP-1 SSAO enzyme inhibitors - Acorda TherapeuticsAlternative Names: BTT-2027; VAP-1 SMI; VAP-1 SSAO enzyme inhibitor; Vapill
Latest Information Update: 02 Mar 2017
Price : *
At a glance
- Originator Biotie Therapies Corp.
- Class Small molecules
- Mechanism of Action AOC3 protein inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Inflammation